strateg move attract price
page full analyst note dec
conduct analyst
govern code ethics/cod conduct
polici secur trade polici
equival invest research
interest visit
primari analyst cover compani
stock
research dec
estim
price data feb
rate updat feb
currenc amount express
valuat growth profit
methodolog valu compani
domin dialysi market make compani
standout provid health servic industri
oper risk reimburs pressur shift busi
model healthcar partner merger creat littl
sharehold valu opinion regardless strength
larger dialysi segment remain foundat
compani earn potenti econom moat
sever measur includ same-facil treatment growth
abil off-set reimburs pressur intern cost
control exceed expect strong oper
execut -- combin age popul rise diabet
rate obes epidem
opportun -- sustain healthi demand perform
dialysi segment
despit attract patient volum growth opportun
reimburs challeng continu weigh
earn reimburs tie quality-of-car metric slow
medicar growth healthcar reform recent chang
dialysi bundl reflect diminish drug util
subdu dialysi payment growth littl relief sight patient
cover medicar medicaid account nearli
treatment revenu margin
patient razor-thin thank law requir
month dialysi payment commerci payer
medicar take primari payer littl opportun exist
davita
more-profit
commerci insur patient make compani
expand contribut
think there greater perform uncertainti medic
group segment previous known healthcar partner
oper one well-regard busi model
forefront industri transit toward patient account
integr care nevertheless medicar advantag payment
cut inabl control patient benefit provis
squeez busi insur compani payment
patient manag cost recogn
valuat summari forecast
financi summari forecast
historical/forecast data sourc morningstar estim may reflect adjust
world second-largest dialysi provid
clinic base compani treat nearli patient
end-stag renal diseas deal valu nearli billion davita
merg healthcar partner one largest physician group
manag repres approxim
consolid revenu medic group segment coordin care
nearli member network thousand physician
specialist california florida nevada new mexico arizona
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
page
posit strateg move attract price dec
encourag news sell
medic group segment unitedhealth optum subsidiari
weve consid no-moat busi sinc
begin healthcar partner merger back
weve continu question strateg fit
divis legaci dialysi oper
billion sale price -- higher valuat would
anticip time ebitda estim
repres anoth posit plan make
adjust model dont anticip shift
fair valu estim time medic
group gone think manag team focu
attract dialysi servic busi
continu think possess narrow moat
sale medic group remov signific
drag compani perform view sinc
initi healthcar partner merger medic group
busi face prolong reimburs pressur
especi medicar advantag cut lead
led consider manag turnov well
asset impair may contend
on-going concern commerci insur reimburs
rate patient assist program dialysi
oper think fundament outlook
busi improv without uncertainti medic
group perform manag plan use cash
proce primarili stock repurchas debt reduct
basi
valuat growth profit
lower fair valu estim per share
dialysi busi
follow recent reimburs pressur particularli
commerci market long term assum major
addit consequ recent premium assist
issu industri valuat also continu reflect
outlook reform corpor tax
rate repres fair valu estim
multipl approxim enterpris
value/ebitda multipl
forecast averag annual growth
dialysi servic segment incorpor growth
construct acquisit new clinic expect
larg portion clinic growth occur
intern market compani attempt diversifi
oper build oversea oper scale
forese substanti patient per clinic treatment per
patient growth model nearli averag growth
revenu per treatment larg driven
commerci insur payment rate dialysi
market also assum medic group segment
continu grow high-single-digit pace
next five year win new contract add new
member network expand addit
expect margin taper long term
cost-control integr effort mitig portion
expect reimburs pressur imagin
sustain nearli level profit dialysi segment
cost-sav measur help off-set compani
less profit intern oper attempt
build scale think medic group segment see
slight margin expans recent low-single-digit
oper margin contract competit reimburs
cut higher administr cost geograph
expans limit long-term profit forecast
result oper margin remain close
return invest capit near includ
goodwil capit oper leas
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
page
commerci payer reimburs pressur combin
oper margin particularli medic group
segment lead oper margin return
capit near respect
share worth bear-cas scenario
believ earn narrow econom moat
economi scale larg network dialysi clinic
extens portfolio clinic affili
physician difficult smaller competitor replic
also probabl earn larger increment profit
smaller competitor central administr
oper bulk suppli agreement
oper approxim one third dialysi
clinic main competitor freseniu
medic form rel duopoli nearli
combin share dialysi market recent
began expand dialysi oper intern
market take consider time compani
amass signific share oper scale
merger healthcar partner known
medic group segment immedi contribut
compani moat view motiv lower
oper cost managed-car compani health plan
outsourc patient manag risk medic
group segment turn receiv capit payment
flat rate per patient exchang coordin patient
care although depend contract structur medic
group segment essenti pocket differ
capit payment servic cost network
effici provid
higher-qu lower-cost care method
lower readmiss rate prevent high-cost
give medium uncertainti rate although
medicar
reimburs pressur consider headwind
futur profit compani broad low-cost
per share bull-cas scenario forecast
growth dialysi segment help growth new
clinic includ growth revenu per treatment
driven healthi commerci insur payment
project nearli basi point oper margin
expans base-cas forecast
reimburs pressur effect cost-control
measur greater contribut economi
scale scenario result return invest capit
rise near
includ averag dialysi revenu growth
clinic growth neglig revenu per
treatment growth next five year scenario
assum worse-than-expect medicar
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
page
payer hospit clinic physician patient
combin highli integr commun
healthcar infrastructur believ oper
structur rais custom switch cost lead
despit healthcar partner competit advantag
histor success think busi model easili
player fragment emerg industri
organ health-servic provid develop
coordin care network sinc servic
facil managed-car
compani control insur plan think
middleman like medic group segment possess littl
negoti leverag industri
infanc think high degre uncertainti exist
competit shake industri evolv
although less enthusiast futur
medic group segment think overal strength
econom moat trend manag like continu
expand dialysi market share scale
acquisit smaller competitor clinic particularli
intern market govern price pressur
remain consist headwind
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
page
oa global increas obes diabetes-rel
condit sustain strong demand dialysi
servic long term
larg dialysi oper help sustain low-
cost leadership help insul compani
reimburs pressur affect whole
oth medic group segment high growth potenti
 healthcar industri shift toward
value-bas risk-shar reimburs plan
larg depend
commerci payer futur contract negoti
ofeder govern chang medicar state
budget constraint medicaid keep dialysi
omedicar advantag cut erod profit
medic group segment beyond manag
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
page
equival begin period
total avail debt servic
oblig commit
total oblig commit
adjust free
gener
gener revolv adjust
commit
oper fairli high financi leverag
debt/ebitda typic time similarli
ebitda coverag interest expens histor
consist time although firm stabl
volum trend support rel consist cash flow
compani merger healthcar partner expos
greater oper volatil busi addit
reimburs pressur remain on-going concern
compani abil maintain stabl profit davita
pay dividend recent repurchas share
govern reimburs pressur particularli
medicar depress margin inabl gain
suffici scale compani intern dialysi
oper repres largest risk view
commerci reimburs
growth addit chang bundl payment
compani benefit payer diversif
small grow dialysi oper
intern market govern probe
concern patient inappropri steer
fine could theoret aris use
third-parti premium assist exchange-bas
patient think new rule like limit
futur use practic potenti settlement fine
would probabl rel immateri valuat
think oper risk disrupt technolog
pharmaceut advanc minor concern slow shift
toward home-bas dialysi potenti threat
clinic think clinic-bas hemodialysi remain
high demand due sever ill patient
popul merger healthcar partner acknowledg
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
page
evolut healthcar deliveri may offer
competit advantag long term
skeptic deal creat sharehold valu also
payment cut medicar advantag reduc abil
contract loss inabl enter new geograph
market could spur disappoint earn growth
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
page
repres date owner name posit common share held report holder issuer
share
fund
share
fund
manag histor follow prudent capital-alloc
practic opinion healthcar partner merger
rais red flag manag strong execut
dialysi segment upheld overal posit compani
perform wed rather see manag deploy
capit strengthen firm competit advantag
global dialysi market manag disciplin
strategi expand larg dialysi clinic portfolio
remain prudent use capit view
healthcar partner merger significantli outsid
manag area expertis base larg declin
profit healthcar partner busi
refer medic group segment
convinc deal depress valu creation
time manag
manag divis manag dialysi
clinic expans strategi continu enhanc
compani economi scale merger healthcar
partner provid nearli opportun cost revenu
synergi perspect
compani also
poor perform medic group segment shift
manag structur follow late
merger healthcar partner kent thiri
robert margoli share respons cochairmen
board addit remain ceo
respect oper segment thiri ceo
sinc octob margoli sinc left compani
juli thiri step ceo struggl
healthcar partner divis hand ceo role
dialysi segment javier rodriguez rodriguez arriv
extens execut experi
compani joel ackerman replac jame hilger
cfo march hilger interim cfo sinc march
remain compani chief account offic
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
page
limit addit downsid remaind dialysi
market patient assist particularli within
medic group oper
although recent hurrican ad addit
headwind davita exist reimburs pressur
third quarter firm third-quart result
continu show stabil dialysi busi
help off-set weak medic group
segment manag lower year-end outlook
medic group segment slightli narrow guidanc
kidney care divis base manag earli
preview perform includ kidney
care oper incom billion --
forecast -- plan lower fair valu estim
initi estim leav narrow moat
still low expect medic busi
report oper loss even exclud
million goodwil impair charg recogn
quarter manag note quarter weak
stem unexpectedli high medic cost higher
acuiti patient mix combin delay medicar
advantag payment segment profit
improv compani payment adjust
item combin new contract on-going
although dialysi oper continu face
reimburs challeng -- among commerci
govern payer -- weigh profit
expect current headwind modestli eas weak
reset
commerci contract million headwind
account adjust weigh upcom
result mani factor creat easier
comparison addit follow recent
fallout medicaid-qualifi patient receiv patient
assist exchange-bas insur plan still see
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
page
financi summari forecast
fiscal year end decemb
earn interest tax
return asset
return equiti
valuat summari forecast
equiti
pre-tax debt
weight averag capit
addit estim scenario avail download http //select morningstar com
equival
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
page
data tabl repres base-cas forecast compani report
currenc begin current year fair valu estim may differ
equiti valu per share shown due time valu money adjust case
probability-weight scenario analysi perform
fiscal year end decemb
good sold
depreci amort report separ
impair charg report separ
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
